Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T11:10:57.771Z.
Calculation as of: 2026-10-06T11:10:57.771Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 58a2fa14633c50703c8ff5f7fcb702de1515a66dae0cc773e6a723eda01f3aaa
PEG RATIO
N/A
Market Cap
$13.19B
PEG Ratio
N/A
TTM Avg
6.43
3Y Avg
5.04
5Y Avg
3.49
Market Cap
$12.17B
PEG Ratio
0.95
TTM Avg
1.07
3Y Avg
1.07
5Y Avg
1.07
Market Cap
$12.00B
PEG Ratio
1.39
TTM Avg
2.72
3Y Avg
36.33
5Y Avg
61.65
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | N/A | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | N/A | 2.64 | 6.31 | 6.30 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | N/A | 6.43 | 5.04 | 3.49 |
| Baxter International Inc. (BAX)vs › | $12.52B | N/A | 3.72 | 3.63 | 3.63 |
| Penumbra, Inc. (PEN)vs › | $12.49B | N/A | 4.12 | 4.12 | 4.12 |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 0.95 | 1.07 | 1.07 | 1.07 |
| Encompass Health Corporation (EHC)vs › | $12.00B | 1.39 | 2.72 | 36.33 | 61.65 |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | N/A | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $11.47B | 1.90 | 1.71 | 1.36 | 1.19 |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 10.57 | 10.54 | 3.95 | 7.98 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
